UNSPSC 51343113: Sorivudine
Commodity
Code facts
- Part of
-
-
51000000
-
51340000
- 51343100
-
51340000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51343113
| NIGP code |
|---|
| 26908 Anti-Infective Agents |
Definition
This classification denotes a dihydropyrimidine dehydrogenase inhibitor with the molecular formula C11H13BrN2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C7VOZ162LV, chemically known as 2,4(1h,3h)-pyrimidinedione, 1-beta-d-arabinofuranosyl-5-(2-bromoethenyl)-, (e)- but generally known as sorivudine, which bears US NIH Compound Identifier 5282192. European Medicines Agency schedules Sorivudine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10605MIG.
Read the full definition
The term SORIVUDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). SORIVUDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sorivudine under HS 29349990 and SITC 51579. As of Q4 2014, SORIVUDINE remains the US FDA Preferred Term for this commodity. Sorivudine bears US NLM identifiers UMLS ID C0207628 and NCI Concept Code C1460. SMILES: C1=C(C(=O)NC(=O)N1C2C(C(C(O2)CO)O)O)C=CBR.
About UNSPSC 51343113
UNSPSC 51343113 Sorivudine is a Commodity code that encompasses pharmaceutical products and related medical supplies procured by state and local health agencies. Recent opportunities posted under this code show state and local governments buying prescription pharmaceuticals, naloxone, and drug deactivation systems for public health programs and emergency response. The issuing bodies include state health departments and county health authorities, typically through cooperative purchasing consortiums (such as MMCAP Infuse) or direct competitive bidding processes. Vendors must comply with drug-free workplace certification, E-Verify requirements, and applicable federal regulations when FEMA funding is involved, and may be required to maintain commercial general liability and workers' compensation insurance.
The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under an Invitation for Bid process, with an initial 12-month term and two optional renewal years. Seminole County, Florida issued an IFB (IFB60459723LAS) on June 30, 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building and a two-year initial term plus one-year renewal option. Recent activity under the code spans Illinois and Florida, with procurement vehicles emphasizing competitive bidding and cooperative purchasing access.
Quick answers
What is UNSPSC 51343113?
UNSPSC 51343113 is Sorivudine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51343113?
UNSPSC 51343113 maps to 1 NIGP code, 26908 Anti-Infective Agents.
On GovTribe
See everything under UNSPSC 51343113
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code